Novo Nordisk
SKU: 55755
Wegovy (0.5mg) is a weight loss medication approved by the FDA that helps you control your appetite and lose weight. It is a once-weekly, prefilled injection pen FlexTouch®. It belongs to the class of GLP‑1 receptor agonists, mimicking the natural hormone GLP‑1 which helps control appetite and enhance feelings of fullness.
Benefits:
- Aids significant weight loss and long-term weight control in adults with obesity (BMI ≥ 30 kg/m²) or overweight individuals (BMI ≥ 27 kg/m²) with associated health conditions.
- Helps reduce the risk of serious heart-related events in adults with cardiovascular disease.
- Approved for weight management in adolescents aged 12 and older with obesity (weight over 60 kg), when lifestyle adjustments alone are insufficient.
Main Ingredient & Its Benefits:
- Semaglutide: A synthetic GLP‑1 agonist that promotes satiety, reduces appetite, slows gastric emptying, supports weight reduction, and metabolic improvements.
Benefits:
- Aids significant weight loss and long-term weight control in adults with obesity (BMI ≥ 30 kg/m²) or overweight individuals (BMI ≥ 27 kg/m²) with associated health conditions.
- Helps reduce the risk of serious heart-related events in adults with cardiovascular disease.
- Approved for weight management in adolescents aged 12 and older with obesity (weight over 60 kg), when lifestyle adjustments alone are insufficient.
Main Ingredient & Its Benefits:
- Semaglutide: A synthetic GLP‑1 agonist that promotes satiety, reduces appetite, slows gastric emptying, supports weight reduction, and metabolic improvements.
Semaglutide, Sodium Chloride, Sodium Phosphate Dibasic Heptahydrate, Water for injection, Hydrochloric acid solution.
Recently Viewed